kawasaki
diseas
kd
acut
vascul
unknown
origin
predominantli
involv
coronari
arteri
lead
condit
caus
acquir
heart
diseas
children
unit
state
first
report
japan
year
ago
origin
diagnost
clinic
criteria
defin
dr
kawasaki
still
authent
diseas
recogn
worldwid
affect
mostli
infant
young
children
rare
teenag
kd
character
fever
polymorph
rash
conjunct
mucos
chang
hand
feet
unilater
cervic
lymphadenopathi
howev
hallmark
diseas
coronari
arteri
abnorm
mainli
aneurysm
develop
approxim
untreat
patient
report
aim
give
updat
epidemiolog
etiolog
pathogenesi
manag
enigmat
diseas
epidemiolog
kd
first
describ
dr
tomisaku
kawasaki
acut
febril
selflimit
multisystem
vascul
almost
exclus
affect
young
children
although
hla
associ
identifi
yet
incid
kd
significantli
increas
japan
korea
among
asianamerican
children
unit
state
suggest
kd
underli
genet
predisposit
import
seriou
ill
annual
estim
incid
japan
case
per
children
younger
year
age
howev
incid
kd
among
americanindian
alaskan
nativ
children
younger
year
old
found
per
despit
asian
ancestr
origin
children
new
recent
report
indic
annual
incid
african
american
hispan
caucasian
children
younger
year
old
per
respect
unit
state
figur
children
american
asian
pacif
island
origin
report
higher
per
kd
common
young
children
peak
incid
month
age
rare
first
month
life
case
occur
year
age
despit
two
decad
intens
research
caus
kd
remain
unknown
howev
sever
observ
suggest
diseas
trigger
unknown
infecti
agent
first
clinic
pictur
kd
overlap
infecti
diseas
scarlet
fever
adenovir
infect
addit
kd
season
occurr
season
peak
kd
winterspr
similar
seen
numer
viral
diseas
third
epidem
clear
epicent
tempor
cluster
report
unit
state
japan
worldwid
japan
outbreak
observ
start
one
area
spread
throughout
countri
period
month
fourth
kd
peak
incid
toddler
case
toddler
less
year
old
rare
case
month
age
suggest
protect
transplacent
antibodi
despit
observ
studi
conduct
far
fail
identifi
virus
parvoviru
retroviru
epstein
barr
viru
herp
measl
recent
human
coronavirus
caus
agent
kd
yet
evid
found
prove
causal
particular
viru
similar
viral
ill
bacteri
diseas
link
kd
fever
clinic
manifest
kd
mucou
membran
lesion
desquam
skin
rash
overlap
welldefin
infecti
toxinmedi
diseas
staphylococc
streptococc
toxic
shock
syndrom
tss
scarlet
fever
abinum
cant
report
tss
toxinsecret
staphylococcu
aureu
isol
patient
kd
manifest
coronari
arteri
aneurysm
caa
other
describ
simultan
present
kd
tss
adolesc
male
specul
infect
produc
immunemedi
reaction
caus
sign
symptom
diseas
immunogenet
suscept
host
propos
kd
tss
diseas
caus
viral
bacteri
toxin
act
superantigen
superantigen
protein
bypass
convent
highli
complic
antigenpres
mechan
bind
v
v
region
tcell
receptor
conjunct
major
histocompat
complex
class
ii
molecul
result
releas
enorm
amount
proinflammatori
cytokin
eg
tumor
necrosi
factor
tnf
interleukin
il
mediat
diseas
process
result
clinic
pictur
kd
tss
control
trial
leung
et
al
found
superantigenproduc
bacteria
present
kd
patient
p
howev
find
could
confirm
other
although
data
support
superantigen
theori
yet
conclus
clinic
immunolog
similar
kd
tss
strike
due
similar
kd
acrodynia
mercuri
hypersensit
studi
link
kd
drug
toxin
chemic
heavi
metal
reveal
neg
result
kd
manifest
rel
prolong
fever
rash
conjunct
mucou
membran
chang
cervic
lymphadenopathi
chang
hand
feet
seriou
complic
uniqu
ill
develop
acut
coronari
arteri
vascul
dilat
aneurysm
format
earli
impress
diseas
selflimit
benign
condit
howev
subsequ
report
suggest
patient
die
coronari
abnorm
untreat
patient
develop
caa
ectasia
addit
kd
may
lead
myocardi
infarct
sudden
death
ischem
heart
diseas
earli
phase
diseas
develop
edema
neutrophil
infiltr
rapid
transit
mononuclear
cell
primarili
cell
monocyt
macrophag
immunoglobulin
plasma
cell
coronari
arteri
wall
follow
product
matrix
metalloproteinas
caus
destruct
intern
elast
lamina
media
progress
replac
intima
media
fibrou
connect
tissu
lead
format
aneurysm
scar
stenosi
report
avail
children
kd
develop
coronari
abnorm
acut
phase
diseas
die
year
later
due
unrel
caus
autopsi
perform
children
demonstr
coronari
arteri
intim
thicken
medial
fibrosi
diagnosi
kd
diagnosi
base
clinic
sign
symptom
uniqu
laboratori
diagnost
test
exist
diseas
kawasaki
et
al
describ
princip
criteria
diagnosi
kd
base
japanes
kawasaki
diseas
research
committe
later
us
center
diseas
control
prevent
adopt
criteria
criteria
guidelin
prevent
misdiagnosi
overdiagnosi
howev
clinician
awar
case
kd
incomplet
sign
symptom
fulfil
criteria
ie
incomplet
atyp
kd
case
insuffici
clinic
criteria
proof
presenc
coronari
abnorm
caa
must
shown
echocardiogram
absenc
diagnost
test
criteria
becom
highli
import
pivot
diagnos
patient
kd
laboratori
test
may
support
acut
phase
reactant
includ
erythrocyt
sediment
rate
creactiv
protein
crp
significantli
elev
seen
typic
inflammatori
disord
degre
found
common
viral
infect
base
multicent
studi
patient
kd
treat
intraven
immunoglobulin
ivig
beiser
et
al
develop
predict
instrument
risk
caa
accord
studi
higher
count
neutrophil
band
platelet
addit
low
level
hemoglobin
lack
defervesc
within
first
day
ivig
treatment
associ
higher
risk
investig
recommend
frequent
cardiac
test
would
unnecessari
lowrisk
patient
kd
japan
harada
treat
kd
patient
ivig
fulfil
four
follow
criteria
within
day
onset
leukocyt
count
greater
platelet
greater
crp
greater
mgdl
hematocrit
less
albumin
less
gdl
age
month
younger
male
gender
mori
et
al
show
rise
white
blood
cell
count
crp
ivig
infus
independ
predictor
caa
recent
nakamura
et
al
propos
kd
low
sodium
level
less
meql
patient
first
visit
hospit
may
predictor
giant
caa
fukunishi
et
al
found
higher
serum
level
crp
lactat
dehydrogenas
bilirubin
predict
failur
respond
ivig
two
recent
report
protect
role
african
american
ethnic
develop
caa
kd
report
abuhammour
et
al
porcalla
et
al
concur
yet
unpublish
data
retrospect
studi
center
children
hospit
new
orlean
referr
center
drawn
popul
compris
african
american
accord
commun
survey
inde
kd
patient
african
american
caucasian
howev
major
develop
caa
caucasian
find
may
support
notion
kd
african
american
ethnic
background
might
play
protect
role
develop
coronari
abnorm
studi
larger
number
patient
requir
assess
signific
find
unit
state
administr
singl
infus
ivig
gkg
given
earli
cours
diseas
within
day
onset
complement
aspirin
mgkgday
four
divid
dose
consid
current
treatment
regimen
success
reduc
durat
fever
preval
caa
kd
highdos
aspirin
import
adjunct
ivig
therapi
suppos
addit
antiinflammatori
effect
kd
twothird
patient
afebril
improv
hour
complet
ivig
infus
afebril
hour
therapi
regimen
effect
reduc
preval
coronari
arteri
abnorm
approxim
patient
may
persist
recrudesc
fever
hour
singl
dose
ivig
infus
patient
risk
develop
coronari
arteri
abnorm
may
benefit
second
ivig
infus
small
subset
patient
remain
febril
despit
second
dose
ivig
therapi
hand
shown
corticosteroid
benefici
refractori
kd
although
conflict
report
exist
literatur
use
oral
intraven
puls
steroid
therapi
kd
sever
recent
case
report
case
seri
suggest
puls
methylprednisolon
therapi
mgkg
given
intraven
may
benefici
patient
ivigresist
kd
report
includ
report
harvard
describ
experi
use
puls
methylprednisolon
therapi
four
ivigresist
kd
patient
earlier
report
japan
kato
et
al
state
steroid
may
potenti
harm
lead
higher
rate
coronari
arteri
abnorm
therefor
use
corticosteroid
therapi
kd
controversi
practic
contraind
studi
shown
steroid
therapi
associ
increas
incid
caa
appar
form
basi
suggest
regard
contraind
corticosteroid
kd
investig
found
patient
kd
group
treat
steroid
alon
develop
caa
compar
four
patient
group
treat
aspirin
alon
although
none
seven
patient
group
treat
steroid
aspirin
develop
caa
author
conclud
find
suggest
steroid
might
act
advers
caus
progress
coronari
lesion
diseas
studi
difficult
interpret
unclear
patient
random
differ
protocol
mention
patient
age
paramet
affect
patient
sever
score
contrari
report
anoth
japanes
retrospect
studi
conduct
kijima
et
al
show
puls
dose
steroid
kd
benefici
prevent
caa
furthermor
previou
recent
studi
possibl
role
corticosteroid
initi
treatment
acut
phase
kd
shown
benefici
howev
recent
multicent
random
doubleblind
control
trial
addit
puls
dose
methylprednisolon
therapi
convent
ivig
therapi
primari
treatment
kd
reveal
length
hospit
stay
number
day
fever
rate
retreat
ivig
number
advers
event
similar
methylprednisolon
placebo
group
corticosteroid
compound
potent
antiinflammatori
agent
treatment
rheumat
diseas
although
mainstay
treatment
chronic
complic
form
vasculitid
ie
polyarter
nodosa
wegen
granulomatosi
takayasu
arter
clinician
rememb
antiinflammatori
dose
steroid
caus
toxic
includ
cushingoid
appear
suppress
growth
gastrointestin
irrit
hypertens
cataract
psychosi
therefor
steroid
use
manag
welldefin
pediatr
indic
proper
way
minim
amount
need
control
diseas
activ
selflimit
autoimmun
diseas
ie
rheumat
fever
purpura
epidemiolog
data
kd
suggest
infecti
trigger
genet
suscept
host
howev
fact
infect
play
role
trigger
condit
contraind
steroid
therapi
steroid
indic
subset
patient
rheumat
fever
purpura
howev
role
treatment
kd
still
unclear
date
data
avail
suggest
steroid
primari
role
manag
kd
data
uncontrol
suggest
secondari
partial
role
therefor
data
avail
small
subset
patient
kd
show
ivig
resist
andor
lifethreaten
complic
given
option
puls
steroid
therapi
prospect
multicent
random
control
trial
need
determin
efficaci
puls
oral
dose
corticosteroid
treatment
ivigresist
kd
discoveri
proinflammatori
cytokin
mainli
tnf
play
pivot
role
pathogenesi
rheumatoid
arthriti
spondyloarthropathi
inflammatori
condit
includ
vascul
encourag
widespread
use
anticytokin
therapi
may
possibl
block
tnfbut
also
import
cytokin
find
open
window
opportun
use
new
biolog
manag
kd
recent
antitnf
infliximab
shown
novel
therapi
refractori
kd
recent
guidelin
american
heart
associ
expert
propos
stratif
system
categor
patient
risk
level
risk
caa
highest
children
kd
miss
opportun
receiv
ivig
within
recommend
time
period
onset
fever
day
patient
persist
fever
despit
ivig
treatment
patient
laboratori
find
suggest
persist
inflamm
increas
erythrocyt
sediment
rate
crp
young
month
older
year
old
children
male
gender
likelihood
progress
coronari
arteri
stenosi
directli
relat
aneurysm
size
especi
high
giant
aneurysm
mm
larger
patient
persist
aneurysm
tend
significantli
higher
level
crp
compar
regress
aneurysm
without
aneurysm
group
patient
kd
longterm
antiplatelet
therapi
warfarin
keep
intern
normal
ratio
lowmolecular
weight
heparin
keep
antifactor
xa
level
uml
necessari
reduc
myocardi
consumpt
blocker
need
contact
highimpact
sport
avoid
reduc
risk
bleed
cardiolog
followup
twice
year
electrocardiogram
echocardiogram
stress
test
myocardi
perfus
scan
highli
recommend
follow
angiographi
ischemia
present
group
kd
patient
includ
individu
angiograph
regress
caa
level
normal
lumen
diamet
within
year
onset
rate
caa
resolut
invers
relat
size
studi
reveal
although
regress
occur
intim
thicken
endotheli
dysfunct
patient
need
treat
lowdos
aspirin
mgkgday
least
aneurysm
regress
proven
cardiolog
followup
perform
annual
electrocardiogram
echocardiogram
stress
test
myocardi
perfus
studi
twice
year
highli
recommend
angiographi
need
evid
ischemia
present
highimpact
physic
activ
limit
guid
regress
aneurysm
occur
week
onset
restrict
beyond
first
week
need
care
assess
counsel
everi
year
recommend
determin
futur
risk
ischem
heart
diseas
longterm
followup
year
onset
morbid
mortal
patient
kd
similar
normal
pediatr
popul
angiographi
necessari
patient
need
antiplatelet
therapi
beyond
recommend
week
onset
care
assess
counsel
everi
year
recommend
determin
futur
risk
ischem
heart
diseas
restrict
physic
activ
beyond
week
necessari
although
infecti
etiolog
seem
like
kd
remain
puzzl
immedi
outcom
kd
improv
significantli
decreas
frequenc
caa
threeto
fivefold
follow
introduct
aspirin
ivig
significantli
small
subgroup
patient
sever
kd
resist
ivig
therapi
risk
subsequ
develop
caa
longterm
sequela
appear
benefit
intraven
puls
steroid
therapi
infliximab
infus
stage
corticosteroid
role
primari
treatment
kd
final
futur
outcom
kd
patient
without
coronari
arteri
chang
unknown
longterm
followup
second
third
forth
decad
monitor
late
cardiovascular
sequela
would
use
determin
role
kd
adult
coronari
heart
diseas
paper
particular
interest
publish
recent
highlight
import
major
import
